International Myotonic Dystrophy Awareness Day to be Observed September 15th

The Neuromuscular Disease Network for Canada (NMD4C) and Muscular Dystrophy Canada (MDC) are proud to be members of a global alliance of myotonic dystrophy (DM) focused organizations who have united to declare an International Day of Awareness for DM, to be observed on the 15th of September each year. This September will mark the inaugural International Myotonic Dystrophy Awareness Day, and there are many exciting events and activities planned from organizations around the world to recognize this day and raise awareness for DM.

Announced on February 28th to honor International Rare Disease Day 2021, International DM Awareness Day aims to garner the attention of the wider general public, policy makers, regulators, biopharmaceutical representatives, researchers, health care professionals, and anyone with an interest in changing the future of myotonic dystrophy. Raising awareness of myotonic dystrophy will help improve service provision, basic research, drug development, and policymaking related to the disease.

One of the network’s ongoing activities around International DM Awareness Day has been to advocate for official recognition by governments at both the provincial and federal level. We are happy to share that through the combined efforts of MDC, the NMD4C, and Myotonic Dystrophy Foundation (MDF) Support Group Facilitator and NMD4C Investigator Teresa Buffone, the Province of Manitoba has officially proclaimed September 15th, 2021 to be International Myotonic Dystrophy Awareness Day! We hope to see further proclamations from the federal and provincial levels of government as we continue to advocate for recognition of this day.

MDC will also be hosting a webinar to recognize this year’s International DM Day. Myotonic 101 with Dr. Cynthia Gagnon will introduce the basic facts and latest research about Myotonic dystrophy. This webinar will answer questions such as:

  •         What is Myotonic muscular dystrophy?
  •         What are the symptoms/signs of Myotonic muscular dystrophy?
  •         How is Myotonic muscular dystrophy diagnosed? Prognosis?
  •         What are treatment options?
  •         What about supportive treatments for Myotonic muscular dystrophy?
  •         What research is being done on Myotonic muscular dystrophy in Canada?

Register here for the event!

 

Further information about International DM Awareness Day can be found on the MDF website here. Check out what other organizations have planned for September 15th, and find out how you can get involved!

International-DM-Awareness-Day-Logo-800px

Read next...

20250508_151830 (1)

NMD4C Hosts 2nd Annual Basic Research Summer School at York University!

The NMD4C is excited to announce a new program for neuromuscular research trainees that will support collaboration opportunities between Canadian research labs.

BUILDING BRIDGES EMAIL BANNER

Making Science Accessible for All Through Collaboration Between Neuromuscular Researchers and Patient Partners!

The NMD4C is excited to announce a new program for neuromuscular research trainees that will support collaboration opportunities between Canadian research labs.

Application to Collaborative Research Awards

Applications Open for New NMD4C Collaborative Research Training Awards!

The NMD4C is excited to announce a new program for neuromuscular research trainees that will support collaboration opportunities between Canadian research labs.

David Green awards from MDC

NMD4C Members Receive Dr David Green Awards from Muscular Dystrophy Canada

We are excited to share that several NMD4C investigators and members have been honored with a Dr David Green Award from Muscular Dystrophy Canada!

GRIMN logo

Lower Extremity Muscle Strengthening Program in Myotonic Dystrophy Type 1 from Groupe de recherche interdisciplinaire sur les maladies neuromusculaires

The Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN) recently created a video aimed at health professionals that provides an in-depth explanation of the Myotonic dystrophy (DM1) training parameters used in their studies.

2026 Clinical Neuromuscular Fellowship Competition poster

Fifth Annual Clinical Fellowship Competition from NMD4C and MDC Opens May 1st

The NMD4C and MDC clinical neuromuscular fellowship competition is accepting applications for the 2026 competition until June 12, 2025.